You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
21 August 2026 - French biopharmaceutical company Ipsen (Euronext Paris:IPN) (ADR:IPSEY) announced on Friday that it has completed the acquisition of Kartos Therapeutics, adding the clinical-stage biopharmaceutical company's late-stage MDM2 inhi...
21 August 2026 - Global oncology company Nuvation Bio Inc (NYSE:NUVB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Fast Track Designation for safusidenib, the company's investigational, oral, brain-penetrant s...
21 August 2026 - Maverix Medical, a healthcare company focused on improving the diagnosis and treatment of lung cancer, announced on Thursday that the US Food and Drug Administration (FDA) granted 510(k) clearance on June 30, 2026 for the Maverix Nar...
21 August 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Thursday that the US Food and Drug Administration (FDA) has granted Premarket Approval (PMA) for RefluxStop, the company'...
20 August 2026 - Pharmaceutical research services provider Charles River Laboratories International Inc (NYSE:CRL) and Medigen Vaccine Biologics Corp (MVC), a developer of vaccines for infectious diseases, announced on Thursday that they are collabor...
20 August 2026 - Clinical stage biotechnology company Annexin Pharmaceuticals AB (FN STO:ANNX) said on Thursday that the World Health Organization (WHO) has selected vanexin as the proposed International Nonproprietary Name (INN) for its drug candida...
20 August 2026 - US-based biotechnology company Pillar Biosciences Inc announced on Wednesday a collaboration with LC-SCRUM-Asia, a lung cancer screening project, and LSI Medience Corporation, a Japanese subsidiary of PHC Holdings Corporation, to sup...